Calcitriol Inhibits the Proliferation of Triple-Negative Breast Cancer Cells through a Mechanism Involving the Proinflammatory Cytokines IL-1β and TNF-α. (10th April 2019)
- Record Type:
- Journal Article
- Title:
- Calcitriol Inhibits the Proliferation of Triple-Negative Breast Cancer Cells through a Mechanism Involving the Proinflammatory Cytokines IL-1β and TNF-α. (10th April 2019)
- Main Title:
- Calcitriol Inhibits the Proliferation of Triple-Negative Breast Cancer Cells through a Mechanism Involving the Proinflammatory Cytokines IL-1β and TNF-α
- Authors:
- Martínez-Reza, Isela
Díaz, Lorenza
Barrera, David
Segovia-Mendoza, Mariana
Pedraza-Sánchez, Sigifredo
Soca-Chafre, Giovanny
Larrea, Fernando
García-Becerra, Rocío - Other Names:
- Ortuño-Sahagún Daniel Guest Editor.
- Abstract:
- Abstract : Triple-negative breast cancer (TNBC) is one of the most aggressive tumors, with poor prognosis and high metastatic capacity. The aggressive behavior may involve inflammatory processes characterized by deregulation of molecules related to the immunological responses in which interleukin-1 β (IL-1 β ) and tumor necrosis factor- α (TNF- α ) are involved. It is known that calcitriol, the active vitamin D metabolite, modulates the synthesis of immunological mediators; however, its role in the regulation of IL-1 β and TNF- α in TNBC has been scarcely studied. In the present study, we showed that TNBC cell lines SUM-229PE and HCC1806 expressed vitamin D, IL-1 β, and TNF- α receptors. Moreover, calcitriol, its analogue EB1089, IL-1 β, and TNF- α inhibited cell proliferation. In addition, we showed that synthesis of both IL-1 β and TNF- α was stimulated by calcitriol and its analogue. Interestingly, the antiproliferative activity of calcitriol was significantly abrogated when the cells were treated with anti-IL-1 β receptor 1 (IL-1R1) and anti-TNF- α receptor type 1 (TNFR1) antibodies. Furthermore, the combination of calcitriol with TNF- α resulted in a greater antiproliferative effect than either agent alone, in the two TNBC cell lines and an estrogen receptor-positive cell line. In summary, this study demonstrated that calcitriol exerted its antiproliferative effects in part by inducing the synthesis of IL-1 β and TNF- α through IL-1R1 and TNFR1, respectively, in TNBCAbstract : Triple-negative breast cancer (TNBC) is one of the most aggressive tumors, with poor prognosis and high metastatic capacity. The aggressive behavior may involve inflammatory processes characterized by deregulation of molecules related to the immunological responses in which interleukin-1 β (IL-1 β ) and tumor necrosis factor- α (TNF- α ) are involved. It is known that calcitriol, the active vitamin D metabolite, modulates the synthesis of immunological mediators; however, its role in the regulation of IL-1 β and TNF- α in TNBC has been scarcely studied. In the present study, we showed that TNBC cell lines SUM-229PE and HCC1806 expressed vitamin D, IL-1 β, and TNF- α receptors. Moreover, calcitriol, its analogue EB1089, IL-1 β, and TNF- α inhibited cell proliferation. In addition, we showed that synthesis of both IL-1 β and TNF- α was stimulated by calcitriol and its analogue. Interestingly, the antiproliferative activity of calcitriol was significantly abrogated when the cells were treated with anti-IL-1 β receptor 1 (IL-1R1) and anti-TNF- α receptor type 1 (TNFR1) antibodies. Furthermore, the combination of calcitriol with TNF- α resulted in a greater antiproliferative effect than either agent alone, in the two TNBC cell lines and an estrogen receptor-positive cell line. In summary, this study demonstrated that calcitriol exerted its antiproliferative effects in part by inducing the synthesis of IL-1 β and TNF- α through IL-1R1 and TNFR1, respectively, in TNBC cells, highlighting immunomodulatory and antiproliferative functions of calcitriol in TNBC tumors. … (more)
- Is Part Of:
- Journal of immunology research. Volume 2019(2019)
- Journal:
- Journal of immunology research
- Issue:
- Volume 2019(2019)
- Issue Display:
- Volume 2019, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 2019
- Issue:
- 2019
- Issue Sort Value:
- 2019-2019-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-04-10
- Subjects:
- Immunology -- Periodicals
Immunology -- Research -- Periodicals
616.07905 - Journal URLs:
- https://www.hindawi.com/journals/jir/ ↗
- DOI:
- 10.1155/2019/6384278 ↗
- Languages:
- English
- ISSNs:
- 2314-8861
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 10617.xml